GASC1 expression to predict response to paclitaxel plus cisplatin in oesophageal squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not ...
An updated overall survival analysis with correction for protocol-planned crossover of the international, phase III, randomized, placebo-controlled trial of regorafenib in advanced gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results